Carbamazepine
Treatment for Idiopathic Epilepsy
Typical Dosage: 600-1200 mg daily
Effectiveness
70%
Safety Score
50%
Clinical Trials
600
Participants
80K
Comparative Safety Scale(Higher is safer)
Cyanide☠️
Meth💀
Cigarettes🚬
Chemo☢️
Alcohol🍺
Morphine💊
Antibiotics💉
Tylenol💊
Exercise🏃
Water💧
50
DangerousModerateSafe
Treatment Details
Dosage Range
600-1200 mg daily
Time to Effect
Days to weeks
Treatment Duration
Lifetime
Evidence Quality
HIGHNumber Needed to Treat (NNT)
7(Treat 7 patients to see 1 additional successful outcome)
Number Needed to Harm (NNH)
9(Treat 9 patients to see 1 additional serious adverse event)
Confidence Score
90%confidence in effectiveness data
Health Economics
Annual Cost of Care
Drug Cost:$500
Monitoring:$700
Side Effect Mgmt:$400
Total Annual:$1,600
Cost-Effectiveness Analysis
Cost-Effectiveness Rating
EXCELLENTICER
$20,000/QALY
QALYs Gained
4
Outcome-Based Costs
Cost per Responder
$4,000
Cost per Remission
$5,333
Carbamazepine Outcomes
for Idiopathic Epilepsy
Efficacy Outcomes
Overall Effectiveness
+70%
Response Rate
+40%
Remission Rate
+30%
Common Side Effects
Dizziness
+15%
Diplopia/Blurred vision
+12%
Ataxia
+12%
Nausea/Vomiting
+8%
Rash (including serious SJS/TEN)
+7%
Hyponatremia
+3%
Leukopenia
+3%
Sources:
Active Clinical Trials
No active trials currently recruiting for this treatment
No active trials found in ClinicalTrials.gov